Related by context. All words. (Click for frequent words.) 65 novel peptides 63 adrenergic regulation 62 Nasdaq ALNY 62 FoldRx 61 lixivaptan 61 CHDI Foundation 61 Apexigen 60 InterfeRx 60 elotuzumab 60 dacetuzumab 60 PLK1 SNALP 60 Intellikine 60 Ceregene 60 Galapagos NV Euronext GLPG 60 Medicilon 60 RAPTIVA R 60 BioInvent 60 AnGes MG Inc. 60 PsychoGenics 60 Syntonix 60 PDL# 60 Qualified Therapeutic Discovery 59 atacicept 59 HuLuc# 59 Tolerx 59 DeveloGen 59 KNS # 59 HuCAL antibodies 59 Hedgehog antagonist 59 Aurora kinase inhibitor 59 & LSE GLPG 59 nicotinic alpha 7 59 Galenea 59 PDE# inhibitors 59 ridaforolimus 59 Kosan dependence 59 FOLOTYN ® 59 Anacor 59 BioGeneriX 59 EnVivo 59 aptamer therapeutics 59 EnVivo Pharmaceuticals 59 CHDI 59 Curaxin 58 Vegenics 58 IDRI 58 outlicensing 58 UVIDEM 58 ArQule Kinase Inhibitor Platform 58 miRNA therapeutics 58 Protexia ® 58 ALN RSV program 58 non nucleoside HCV 58 EpiTherapeutics 58 Nanobody 58 Fresenius Biotech 58 Lung Rx 58 Syrrx 58 Knopp Neurosciences 58 Trizytek 58 QTDP grants 58 Roche SWX ROG 58 TKM Ebola 58 OGeS 58 prostone 58 POTELLIGENT R Technology 58 fostamatinib 58 NASDAQ LGND 58 OncoMed 58 Neurimmune 58 RTP #i 58 HuMax TAC 58 incyclinide 57 Myrexis 57 romazarit 57 SMRI 57 otelixizumab 57 selective S#P# receptor agonist 57 Oncolin 57 Receptos 57 therapeutic monoclonal antibody 57 novel therapeutic antibodies 57 Cellgate Inc. 57 ASONEP 57 Anaphore 57 TRACON Pharmaceuticals 57 NASDAQ ARRY 57 Celladon 57 AB OMXS BINV 57 MJFF 57 PXD# 57 siRNA therapeutics 57 deforolimus 57 Sigma Tau Pharmaceuticals 57 Vaccinex 57 selective androgen receptor modulators 57 NYSE Amex PTN 57 Government Qualifying Therapeutic 57 Affinitak 57 Project QTDP 57 BLA submission 57 AKIP 57 glucokinase activator 57 PentaStaph 57 Caprion 57 KAI Pharmaceuticals 57 VentiRx 57 CoGenesys 57 novel anti infective 57 Plicera 57 tramiprosate ALZHEMED TM 57 Celladon Corporation 57 BioNumerik 57 R#/MEM # 57 Integrated Preclinical 57 NASDAQ ALNY 57 NeuroMedix 57 EHT AGN 57 TKM ApoB 57 betrixaban 56 FoldRx Pharmaceuticals Inc. 56 Trubion Pharma 56 Kyowa Hakko Kirin 56 INSPIRE Trial Phase III 56 Allovectin 7 56 Kaketsuken 56 Oncaspar 56 ZFP Therapeutics 56 HGS# 56 HCD# [002] 56 THALOMID 56 Scynexis 56 Cellzome 56 Naglazyme R 56 Adenosine Therapeutics 56 anticancer therapeutics 56 antisense drug 56 Tarvacin TM 56 JAK3 56 NASDAQ CGEN announced 56 StromaCel Inc. 56 PDE4 inhibitor 56 therapeutic monoclonal antibodies 56 Adnectin 56 commercialize XL# 56 collaborator Genentech 56 CCR9 antagonist 56 Debiopharm 56 Cethrin 56 Ambrx 56 forodesine 56 GED aPC 56 PHX# 56 Syncria 56 DiaPep# 56 pradefovir 56 EGRIFTA TM 56 Merck Serono division 56 Guanilib 56 AERx iDMS 56 CCR5 mAb 56 GlycArt 56 GVAX ® 56 TACI Ig 56 ospemifene 56 Therapeutics CFFT 56 Nanobody ® 56 PF # [002] 56 Quark Biotech 56 AnGes 56 Aviptadil 56 huC# DM4 56 DNDi 56 Potelligent Technology 56 Acetylon 56 initiated Phase 1b 56 Alzhemed TM 56 TOCOSOL Paclitaxel 56 HepeX B 56 ADMETRx 56 HQK 56 Mipomersen 56 Tesmilifene 56 Atugen 56 IAP inhibitors 56 TargeGen 56 OvaRex R 55 LymphoStat B TM 55 Daclizumab 55 NASDAQ PGNX 55 JAK inhibitor 55 SCOLR Pharma 55 Epiphany Biosciences 55 AEG# 55 Phase 2a clinical trials 55 Viamet 55 developing TB4 55 Oncolys 55 volociximab 55 MedGenesis 55 ProMune 55 BD Biosciences segment 55 Albugon 55 recombinant biopharmaceutical 55 Alseres 55 OMJPI 55 Chronogen 55 tiapamil 55 Galderma SA 55 Symphony Icon 55 Prestara 55 Phenomix Corporation 55 Agios Pharmaceuticals 55 Epothilones 55 ChemDiv 55 PEG SN# 55 Virulizin 55 Can Fite 55 Xcytrin R 55 A3 adenosine receptor 55 faropenem 55 Solzira 55 entity NCE 55 Nanobody R 55 Montigen 55 TLR9 agonists 55 AKIP TM 55 ALN HTT 55 NNR Therapeutics 55 vernakalant oral 55 JAK inhibitors 55 PNT# 55 Transfection Reagent 55 Zeatin 55 CORLUX CORT # 55 Belinostat 55 Mpex 55 oral salmon calcitonin 55 Progenics Pharmaceuticals 55 Teplizumab 55 LentiVector technology 55 ENZON 55 elesclomol 55 Icatibant 55 rxRNA 55 Nasdaq ISIS 55 Addrenex 55 NASDAQ ISIS 55 XmAb# 55 Abiraterone acetate 55 IMC #B 55 Miikana Therapeutics 55 RAPTIVA r 55 Memryte 55 WILEX 55 sanofi aventis EURONEXT SAN 55 ViroChem 55 evaluating satraplatin 55 Relypsa 55 LEAD Therapeutics 55 Celator 55 SNT MC# 55 CD# CEA 55 pharmacological chaperone 55 HuMax CD# 55 Trubion Pharmaceuticals Inc. 55 Unit Dose Budesonide 55 ALN PCS 55 tubulin inhibitor 55 phase IIb trial 55 Malaria Venture MMV 55 Wellstat 55 Institute IDRI 55 Corautus 55 Clovis Oncology 55 NovaBay Aganocide compounds 55 TopoTarget 55 novel RNAi therapeutics 55 R#/MEM 55 Isis Pharmaceuticals 55 FASgen 55 Heptares 55 Dacetuzumab 55 ZaBeCor 55 Kosan epothilone program 55 epothilone 55 Igeneon 55 Ophthotech 55 PNP inhibitor 55 pediatric acute lymphoblastic 55 Clavis Pharma 55 HIV protease inhibitor Lexiva 55 aerosolized AAT 55 ZALBIN ™ 55 Aegera 54 Virdante 54 Prednisporin 54 Allovectin 7 ® 54 Alnylam Biotherapeutics 54 Allovectin 7 R 54 Factor VIIa 54 Panzem 54 Ligand 54 NASDAQ DYAX 54 GLPG# 54 DPX Survivac 54 Bezielle 54 Dacogen injection 54 Transition Therapeutics 54 eprodisate KIACTA TM 54 SNS# T 54 trastuzumab DM1 T DM1 54 anti CD3 monoclonal 54 BioSeek 54 Nasdaq VRTX 54 GSK '# 54 Tikvah Therapeutics 54 Starpharma dendrimer 54 Archemix Corp. 54 Durata Therapeutics 54 IRS Qualifying Therapeutic 54 Celera Diagnostics joint venture 54 B. Lynne Parshall 54 MolecularMD 54 RGB # 54 Alnara 54 MacroGenics 54 Cellgate 54 HCV protease inhibitor 54 oral taxane 54 preclinical 54 Consortium MMRC 54 Dextofisopam 54 Tarvacin Anti Viral 54 NASDAQ AVEO 54 LymphoStat B 54 DirectSelect TM 54 RenaZorb TM 54 cardio renal 54 Genaera Corporation 54 Astex 54 interferon gamma 1b 54 NeuroSolutions 54 Illumigen 54 Targeted Chemotherapy 54 GATTEX TM 54 Maxy G# 54 VEGF Trap 54 MEK inhibitor 54 MAXY G# 54 PRNewswire FirstCall Isis Pharmaceuticals 54 personalized cellular immunotherapy 54 TFChem 54 AQ4N 54 MDV# 54 immuno inflammatory diseases 54 omecamtiv mecarbil 54 allosteric modulation 54 Graffinity 54 QTDP 54 AMEX RGN 54 ATL# [001] 54 immatics 54 docetaxel Taxotere R 54 Sunovion 54 Nasdaq ENZN 54 OncoGenex Pharmaceuticals Inc. 54 Viprinex 54 Stapled Peptide 54 Immunotherapeutic 54 squalamine 54 Lenocta 54 JAK2 inhibitor 54 Alnylam #x# 54 EndoBiologics 54 KRN# 54 XL# XL# XL# XL# 54 EndoTAG TM 54 Pharnext 54 Portola Pharmaceuticals 54 Santaris 54 Raf kinase inhibitor 54 Regulus Therapeutics 54 Taiho Pharmaceutical 54 STEDESA 54 ATryn ® 54 ASG 5ME 54 PharmaBio Development 54 Xencor 54 QTDP program 54 Gemin X 54 Bioral 54 SARcode 54 InvaGen 54 Quark Pharmaceuticals 54 Ligand proprietary 54 Troxatyl 54 Orapred ODT 54 Provid Pharmaceuticals 54 Virulizin R 54 Nasdaq RDEA 54 BEXXAR 54 Captisol ® 54 KineMed 54 OMP #R# 54 AKT inhibitor 54 Epitomics 54 dirucotide MBP# 54 Solazed 54 AKIP ™ 54 Inc. Nasdaq INFI 54 research anddevelopment 54 PRNewswire FirstCall Neurogen 54 Medigen 54 Idera Pharmaceuticals 54 Insegia 54 Panzem R 54 Sopherion 54 Ablynx 54 MacroPore 54 AZD# TC 54 novel antibody therapeutics 54 Etubics 54 DOS# 54 synthetic retinoid 54 anticoagulant reversing agent 54 ActivX 54 Lpath 54 alvespimycin 54 Affitech 54 Epizyme 54 nitric oxide donating prostaglandin 54 FORMA Therapeutics 54 Amorfix 54 CoMentis 54 CIP TRAMADOL ER 54 diabetes irritable bowel 54 PROMACTA ® 54 Ascent Therapeutics 54 MorphoSys proprietary 54 Charlesson 54 BioFocus DPI Galapagos 54 CB2 selective 54 Biovitrum 54 Symphony GenIsis 54 Biotica 54 Aegera Therapeutics 54 Inc. NASDAQ ZLCS 54 BioFocus 54 NASDAQ PCYC 54 SonoLysis 54 Nasdaq MBRX announced 54 Janssen Pharmaceutica NV 54 LY# [003] 54 copromotion 54 oral prodrug 54 Creabilis Therapeutics 54 PI3K/Akt pathway inhibitor 54 MBRX 54 EP #R 54 Ixempra 54 Sage Bionetworks 54 QTDP grant 54 JUVISTA 54 Pimavanserin 54 SCOLR 53 OTCBB HXBM developer 53 SARMs 53 Takeda Pharmaceutical Company 53 Virulizin ® 53 TESARO 53 NV Organon 53 investigational therapies 53 Panzem R NCD 53 Zor Pharmaceuticals 53 commercialize dutogliptin 53 BioWa 53 Tarvacin 53 Bresso Italy 53 Fanapt ™ 53 preclinically 53 CIMZIA r 53 E1 INT TM 53 molecular chaperone regulation 53 HuCAL GOLD 53 targeting CD# 53 Research MJFF 53 Oasmia 53 CRACM 53 BCR ABL inhibitor 53 PROMACTA 53 Nasdaq LEXG 53 Bicifadine 53 Biolipox 53 Stimuvax R 53 Sulonex 53 Biomarker Discovery 53 Esprit Pharma 53 microRNA therapeutics 53 Evoltra ® 53 antibody humanization 53 Pancreate 53 Cenomed 53 INCB# [001] 53 Ercole Biotech 53 Cenix 53 Fibrillex TM 53 Protexia R 53 Loramyc R 53 FivePrime 53 Georges Gemayel 53 TELINTRA 53 NeuroSearch 53 Catena ® 53 ASONEP TM 53 UltiMAb 53 Alnylam Nasdaq ALNY 53 Cardiokine 53 Gastrotech 53 Zalypsis 53 hepatitis C polymerase inhibitor 53 Kiadis Pharma 53 selective androgen receptor modulator 53 Inflazyme 53 Durect 53 exon skipping 53 Seeding Drug 53 NASDAQ INFI 53 iSONEP 53 ocrelizumab 53 Nycomed GmbH 53 celgosivir 53 Squalamine 53 Phase #b/#a clinical 53 proprietary phage display 53 Urocortin 2 53 Xcellerated T Cells 53 NPC 1C 53 Medidur FA 53 RAPTIVA 53 Zacharon 53 Cerimon 53 Nasdaq IDRA 53 ViroChem Pharma Inc. 53 SCIB1 53 BioMarin Genzyme LLC 53 ImmuneWorks 53 vaccines oncolytic virus 53 Intravenous CP 53 Asentar 53 ChemoCentryx 53 Vaxfectin 53 Tacere 53 Nasdaq LXRX biopharmaceutical 53 REGENERX BIOPHARMACEUTICALS INC. 53 lumiliximab 53 novel antiviral therapeutics 53 L BLP# 53 IAP inhibitor 53 Alder Biopharmaceuticals 53 novel VDA molecule 53 ularitide 53 NTDDS 53 Onconase 53 IMiDs 53 Canvaxin 53 pralatrexate injection folate analogue 53 Morphotek 53 kidney urologic 53 phase IIa clinical 53 Trubion Pharmaceuticals TRBN 53 Azedra 53 MT#/MEDI-# 53 Archexin 53 HELSINN 53 stem cell therapeutics 53 Celltrion 53 DF HCC 53 Exelixis 53 LFB Biotechnologies 53 Metabolex 53 Knopp Biosciences 53 refractory chronic lymphocytic 53 Nippon Shinyaku 53 AEterna 53 5 lipoxygenase activating 53 HuMax CD4 53 ELND# 53 QuatRx 53 Lexicon Genetics 53 Vernalis plc 53 entinostat 53 Symphony ViDA 53 MAGE A3 ASCI 53 Flamel 53 Aeras 53 RNA antagonists 53 Thalomid ® 53 LSE ASM 53 rhMBL 53 Itero 53 WRAIR 53 Janssen Alzheimer Immunotherapy 53 SAR# [004] 53 CAMPATH 53 epigenetic therapies 53 Metabasis 53 Inpharmatica 53 ESBATech 53 Phase Ib study 53 BioAxone 53 GeoVax AIDS vaccine 53 CRADA 53 PrevOnco 53 Chemokine 53 Hematide ™ 53 OncoTherapy Science 53 Janssen AI 53 SBIR grant 53 drug GAP #B# 53 Tyzeka Sebivo 53 AAG geldanamycin analog 53 Hsp# inhibition 53 GSK # 53 small molecule agonists 53 OTCBB PYTO FWB ET6 53 Campath ® 53 Cascade LifeSciences 53 MAXY alpha 53 Relivar 53 Profectus BioSciences 53 Vancocin R 53 developing adecatumumab 53 Trubion Pharmaceuticals 53 CytoFab 53 SGLT Inhibitors 53 YONDELIS 53 TaiGen 53 Juvantia 53 Inc. NASDAQ ICGN 53 Synavive 53 OvaRex ® MAb 53 Evotec OAI 53 NOXXON 53 Sylvie Gregoire President 53 Theratope 53 Santhera 53 NYSE Amex ANX 53 NeoGenesis 53 Arqule 53 BioFocus DPI 53 aldehyde dehydrogenase ALDH2 deficiency 53 BHT DNA 53 Milestone Payment From 53 pafuramidine 53 CEFF financings subject 53 ALTROPANE R 53 DsiRNA 53 Preotact 53 RNAi therapeutic targeting 53 NRGN 53 Plexxikon proprietary 53 drug ISA# 53 CINOD 53 CEQ# 53 IL# PE#QQR 53 commercialize deforolimus 53 Phenomix 53 Isis Pharma 53 MPL adjuvant 53 Proellex TM 53 epothilones 53 Æterna Zentaris 53 dutogliptin 53 H3 Biomedicine 53 NIGMS 53 Locked Nucleic Acid 53 NASDAQ TGEN 53 Cytokinetics Incorporated NASDAQ CYTK 53 RhuDex 53 ALS #-# 53 nonclinical studies 53 Nasdaq CGEN 53 methylnaltrexone 53 Symphony Allegro 53 BCR ABL inhibitors 53 Harbor BioSciences 53 MKC# MKC# PP 53 VaxImmune 53 Metabasis Therapeutics Inc. 53 HemoGenix 53 Akorn Strides 53 vosaroxin 53 Xerecept 52 Expression Genetics 52 phase IIb clinical 52 Enobia 52 Hedgehog agonist 52 dirucotide 52 ganetespib 52 Zenyaku Kogyo 52 acyclovir Lauriad R 52 talactoferrin 52 resolvin 52 NEUGENE R 52 miRagen 52 ViiV Healthcare 52 cathepsin K inhibitor 52 Sym# 52 Excaliard 52 Cellerant 52 Isotechnika Pharma 52 Merck KGaA Darmstadt Germany 52 Roche Trimeris 52 Palatin Technologies Inc. 52 vidofludimus 52 PDE# 52 registrational studies 52 Amarantus 52 NITD 52 Personalized Immunotherapy 52 SCYNEXIS 52 Receives Milestone Payment 52 Harry Palmin President 52 ImQuest 52 antisense drugs 52 RNAi Consortium 52 Nasdaq RIGL 52 Prolexys 52 HaptoGuard 52 Amplimmune 52 apaziquone 52 XERECEPT 52 Perlegen 52 Neuraltus 52 Ibis Biosciences 52 Ligand Pharmaceuticals Incorporated 52 bicifadine 52 BioMS 52 XmAb 52 RNA interference RNAi therapeutics 52 Initiates Phase II 52 Evolva 52 Foundation SMGF 52 Dynogen 52 BioGeneriX AG 52 OMNARIS Nasal Spray 52 LGLS 52 protein homeostasis 52 THR beta agonist 52 Cerashield 52 Dyax phage display 52 developing ostarine selective 52 Ore Pharmaceuticals 52 Nasdaq IDRA today 52 OncoSec 52 Cetrorelix 52 Romidepsin 52 Project QTDP program 52 NASDAQ FLML 52 drug conjugate 52 AMRIX 52 Civacir 52 Resolvyx 52 NASDAQ ARIA 52 tiered royalties 52 Reata Pharmaceuticals 52 LX# LX# LX# 52 Chemokine Therapeutics 52 FivePrime Therapeutics 52 Multiple Ascending Dose 52 TYGACIL 52 targeted radiotherapeutic 52 Nasdaq TRBN 52 Zenvia ™ 52 AMEX TTP 52 Avicena 52 CDP# 52 oral talactoferrin 52 PATH Malaria Vaccine Initiative 52 XL# XL# 52 Synt em 52 eniluracil 52 QTDP Program 52 carcinoid syndrome diabetes 52 AMPK activators 52 TRAIL receptor antibodies 52 apricitabine ATC 52 Plexxikon 52 MYDICAR ® 52 ADR IPSEY 52 Nasdaq OMER 52 Fleximer 52 Ceflatonin R 52 epoprostenol sodium 52 Nuvion 52 GlycoMimetics 52 Affibody 52 Commercialization Agreement 52 BioCritica 52 Inc. AMEX YMI 52 P#X# antagonist 52 Prosensa 52 BioLineRx 52 Array BioPharma 52 multi kinase inhibitor 52 PRX # 52 novel immunotherapies 52 mGluR2 positive 52 Anticalin 52 DNage 52 Beike Holdings 52 Syndax 52 Proteostasis 52 Furiex Pharmaceuticals 52 Oracea TM 52 Omeros Corporation 52 ImmuPharma 52 Sangamo ZFP technology 52 Foundation MMRF 52 Xanafide 52 LEUKINE 52 AkaRx 52 SinuNase ™ 52 daclizumab 52 Foundation ADDF 52 CR# vcMMAE 52 Trophos 52 HuMax 52 antibody MAb 52 Paramount BioSciences 52 Novexel 52 reslizumab 52 Nautilus Biotech 52 drug conjugate ADC 52 ONTAK 52 oncolytic virus therapies 52 Teikoku Pharma USA 52 GeneICE 52 systemic RNAi 52 TSX TKM 52 RECOTHROM R 52 Nasdaq VICL 52 Biomarin 52 Idun Pharmaceuticals 52 NASDAQ OMER 52 ongoing Phase IIIb 52 pentadentate logo R 52 Dynavax 52 Peptimmune 52 VitiGam 52 PDE7 52 Euroscreen 52 Actimmune R 52 FluINsure 52 PRAECIS 52 Paris IPN Euronext 52 Xenon Pharmaceuticals 52 ALN TTR 52 Aganocide 52 Aganocide ® 52 CCX# 52 Proteolix 52 HCV protease inhibitors 52 Urocidin TM 52 nitric oxide donating 52 TÎ ² 4 52 Source MDx 52 predictive biomarkers 52 Microbia 52 Amigal 52 regenerative medicine therapies 52 mSEPT9 biomarker 52 Immune Tolerance Network 52 BioDelivery Sciences 52 SBIR Grant 52 CompoZr 52 telomerase therapeutic 52 NASDAQ ABII 52 Kosan motilin agonist 52 Gentamicin Surgical Implant 52 Fortical ® 52 MIGENIX 52 develop selective androgen 52 Ocrelizumab 52 targeted anticancer therapies 52 Nicholas Nicolaides 52 Debiopharm SA 52 EGEN 52 Phase lll 52 ALTANA Pharma 52 psoriasis rheumatoid arthritis 52 Nasdaq PCYC 52 OHR/AVR# 52 custirsen 52 Zalbin 52 Inc. NASDAQ ORXE 52 Fumapharm 52 VentiRx Pharmaceuticals 52 ArQule 52 Milestone Payments 52 NGFN 52 immunotherapeutic vaccine 52 Lucanix R 52 OTCBB CTIX 52 cyclophilin inhibitors 52 commercialize AzaSite 52 Cutanea Life Sciences 52 Tragara 52 Aureus Pharma 52 novel immunomodulatory 52 Eureka Genomics 52 KIACTA TM 52 Graffinity Pharmaceuticals 52 Myocet 52 Inspiration Biopharmaceuticals 52 Transition Therapeutics Inc. 52 CyDex 52 Aryx 52 Micromet 52 Lycera 52 InterfeRx TM 52 confirmatory Phase III 52 Symadex 52 R sorafenib tablets 52 InterfeRx license 52 Infinity Pharmaceuticals 52 Surfaxin LS 52 CTSAs 52 motexafin gadolinium Injection 52 ANTEGREN 52 NASDAQ OGXI 52 Inotek 52 Phase Ib 52 Cogane 52 humanized anti 52 JAK1 52 Ortho Biotech Oncology 52 Merrimack Pharmaceuticals 52 Orphan Therapeutics 52 torezolid phosphate 52 oral fludarabine 52 Merck Serono 52 BXT # 52 Protiva Biotherapeutics Inc. 52 EOquin TM 52 anti CD# antibodies 52 Fabry Disease 52 Litx 52 PhG alpha 1 52 Marcadia 52 Azmacort R 52 Eligen ® Technology 52 Agensys subsidiary 52 bafetinib 51 Melior Discovery 51 4SC AG ISIN DE# 51 PATH MVI 51 oral antiplatelet agent 51 HIV integrase inhibitors 51 Nasdaq RXII 51 HPCGG 51 SynCo 51 Genentech BioOncology 51 XL# anticancer compounds 51 Cellegesic 51 Adrian Hobden Ph.D. 51 Curis 51 thalidomide Thalomid 51 HuMax EGFr 51 Galore Creek Partnership 51 Tß4 51 candidate epratuzumab 51 Oncotype DX colon cancer 51 Tavocept 51 CDRD 51 BIIR 51 Quark Biotech Inc. 51 iOWH 51 mda 7 51 EC Cysteamine 51 ARIKACE ™ 51 ATL# [002] 51 Marqibo TM 51 Response Genetics 51 commercialize becocalcidiol patented 51 Lexicon Pharmaceuticals 51 Tarmogen 51 AMEX ISV 51 BIOCEUTICALS 51 Phenoptin 51 Nasdaq SGEN 51 immunotherapeutics 51 BAY #-# 51 Novartis NVS Snapshot Report 51 Poly ICR 51 Nasdaq MNKD 51 Taligen Therapeutics 51 DEB#